Related by context. All words. (Click for frequent words.) 64 Onconase 63 anti CD3 62 immune modulatory 62 Tarvacin 61 molecularly targeted 61 Interferon Alpha 61 SERMs 61 HyACT 61 Temsirolimus 60 pDNA vaccines 60 synthetic retinoid 60 CBLC# 60 Panzem 60 thalidomide Thalomid 59 potent antiproliferative 59 amifostine 59 humanized monoclonal 59 Angiolix 59 radionuclide therapy 59 immunoregulation 59 Squalamine 59 antimitotic 59 liposome formulation 59 vivo validation 59 cytoprotective 59 small molecule activators 59 Thiovir 59 Pertuzumab 59 EP #R 59 plasmid DNA vaccine 59 therapeutic monoclonal antibody 59 liposomal formulation 59 preclinical efficacy 59 mGluR2 NAM 59 dasatinib Sprycel 59 nanoviricides 58 cancer immunotherapies 58 cationic lipid 58 imatinib Gleevec ® 58 proteasome inhibitor 58 EndoTAG TM 58 Nanobody 58 inhibit metastasis 58 XYOTAX TM 58 vivo potency 58 anti CD# antibodies 58 anticancer therapeutics 58 VitiGam 58 Lpathomab 58 PEGylated interferon 58 HuLuc# 58 nanoviricide 58 vidofludimus 58 Eribulin 58 Nanobody ® 58 predictive toxicology 58 humanized monoclonal antibodies 58 cediranib 58 PhG alpha 1 58 flavopiridol 58 p# biomarker 58 Dasatinib 58 gefitinib Iressa 58 A3 adenosine receptor 58 JAK inhibitors 58 epigenetic therapies 58 Tumorgraft 58 Epidermal Growth Factor Receptor 58 Symadex 58 novel immunotherapeutic 58 Locked Nucleic Acid LNA 58 GW# [003] 58 ospemifene 58 YONDELIS R 58 murine models 57 NEUGENE R 57 TÎ ² 4 57 Litx 57 monoclonal antibody mAb 57 paclitaxel Taxol 57 BAL# [001] 57 PORxin TM 57 NEUGENE 57 immune modulating 57 Liposomal 57 nucleotide analogs 57 MEK inhibitors 57 antiangiogenic agents 57 cyclophilin inhibitors 57 RECOTHROM R 57 Interferon alpha 57 drug GAP #B# 57 Curaxin 57 PET tracers 57 CINTREDEKIN BESUDOTOX 57 HSP# inhibitor 57 Kinase inhibitors 57 multikinase inhibitor 57 OMP #M# 57 Muraglitazar 57 selective modulator 57 renin inhibitors 57 IRX 2 57 ESBA# 57 solithromycin 57 intranasal delivery 57 Spiegelmer 57 IV Busulfex 57 cancer vaccine Norelin 57 tubulin binding 57 HuMax TAC 57 depsipeptide 57 YONDELIS 57 Factor VIIa 57 anti angiogenic therapies 57 GIPET 57 immunomodulatory 57 antiangiogenic 57 panitumumab Vectibix 56 acadesine 56 BRAF inhibitors 56 CD# monoclonal antibody 56 reslizumab 56 VDAs 56 cytotoxics 56 biologic therapeutics 56 radiation sensitizer 56 Azedra 56 LEAPS TM 56 TriGrid ™ 56 protein tyrosine phosphatase 56 Bucindolol 56 mda 7 56 OvaRex ® MAb 56 Archexin 56 Cardiotoxicity 56 Angiocept 56 potency selectivity 56 preclinically 56 MGd 56 patented Bioral 56 prophylactic vaccine 56 ENMD # 56 monoclonal antibody MAb 56 Peptidomics 56 cathepsin K inhibitor 56 Tigecycline 56 Zysolin TM 56 Octreotide 56 cytotoxicity assays 56 Anavex #-# 56 XP #L 56 Velcade bortezomib 56 chimeric monoclonal antibody 56 Fenretinide 56 DXL# 56 virosome 56 cellular cytotoxicity 56 Afatinib 56 tkRNAi technology 56 fluoroquinolone antibiotic 56 Liprostin 56 Epratuzumab 56 HDL Selective Delipidation 56 AVI NEUGENE 56 #ME# 56 Somatostatin 56 Sphingomab 56 fusion inhibitor 56 proteasome inhibitors 56 vorinostat 56 receptor inhibitor 56 novel peptide 56 histamine dihydrochloride 56 Immunotherapeutic 56 intratumoral injection 56 FVIIa 56 Blinatumomab 56 vascular disrupting agent 56 peptidomimetic 56 Deforolimus 56 CTAP# Capsules 56 Fulvestrant 56 XmAb# 56 lymphoid malignancies 56 Acute Radiation Syndrome ARS 56 Pyridorin 55 immunotherapeutic vaccine 55 immunosuppressive regimens 55 PROCHYMAL 55 histone deacetylase inhibitor 55 telomerase activator 55 receptor tyrosine kinase inhibitor 55 Adnectin 55 mertansine 55 adenoviral 55 Actimmune ® 55 radiotherapeutic 55 zoledronic acid Zometa 55 Anti Phospholipid Therapy 55 anti CD3 monoclonal 55 mediated inhibition 55 immunoconjugate 55 oral salmon calcitonin 55 BZL# 55 Cytotoxic 55 MAPK signaling pathway 55 potent cytotoxic 55 TRAIL receptor antibodies 55 Intravenous CP 55 nucleotide analog 55 Amrubicin 55 synthase TS 55 DACH platinum 55 PSMA ADC 55 HQK 55 radiolabeled 55 drug zotarolimus 55 antiproliferative effects 55 Lauriad 55 GelSite R polymer 55 cMET 55 Pegylated Interferon 55 Interferon Beta 55 NV1FGF 55 ON #.Na 55 trastuzumab DM1 55 deacetylase inhibitors 55 immunomodulation 55 Fc fusion protein 55 Apaziquone 55 TLR9 agonist 55 trastuzumab DM1 T DM1 55 Safinamide 55 NexACT ® 55 selective inhibition 55 histone deacetylase HDAC 55 drug ISA# 55 lapatinib Tykerb 55 GVAX ® 55 thrombin receptor 55 MYDICAR ® 55 antibody MAb 55 nucleoside analogues 55 ATL/TV# 55 JAK Inhibitor 55 Thrombin 55 Nexavar sorafenib 55 monocytes macrophages 55 immuno modulatory 55 microtubule inhibitor 55 OHR/AVR# 55 HuMax 55 neuroprotective properties 55 Mucosal 55 biomarker assay 55 Aviptadil 55 FGFR 55 Technosphere ® 55 EGFR HER2 55 Intravail ® 55 Src inhibitors 55 noninfectious uveitis 55 PEG SN# 55 microtubule targeting 55 CDDO Im 55 Modrenal 55 kidney urologic 55 antisense drug 55 bevacizumab Avastin ® 55 neurotrophic 55 hormone gastrin 55 mouse xenograft models 55 AEG# 55 Cerashield 55 tubulin inhibitor 55 Arimidex anastrozole 55 delafloxacin 55 Clusterin 54 Dalbavancin 54 Hedgehog antagonist 54 telomerase inhibitors 54 motesanib diphosphate 54 BAL# [002] 54 anti angiogenic agent 54 Yondelis ® 54 Glycosylation 54 peptide conjugated 54 TNFa 54 BiTE 54 potent suppressor 54 bispecific 54 BioSilicon 54 pro angiogenic 54 alkylating agent 54 targeting CD# 54 SinuNase ™ 54 IgG1 antibody 54 rxRNA 54 antisense inhibitor 54 adalimumab Humira 54 maturation inhibitors 54 murine model 54 oncolytic virus 54 inhibitor RG# 54 SNALP formulation 54 adult mesenchymal stem 54 hERG 54 Degarelix 54 HER2 ErbB2 54 Anti angiogenic 54 fluoroquinolone resistance 54 TLR8 agonist 54 NMDA antagonists 54 angiogenesis inhibitor 54 Cyclosporin 54 Targeted Therapies 54 nonviral 54 organ transplant rejection 54 immunomodulatory properties 54 cilengitide 54 annexin 54 Vectibix panitumumab 54 HepaSphere 54 noscapine 54 leukotriene pathway 54 TOCOSOL 54 antitumoral 54 GHRH 54 mGlu2 3 54 MAGE A3 ASCI 54 Bruton tyrosine kinase Btk 54 Glypromate 54 NOD mouse 54 mapatumumab 54 CCX# 54 antifibrotic 54 Neulasta R 54 VNP#M 54 targeted antifolate 54 Insegia 54 LungSign TM 54 Gleevec resistant 54 Calcitonin 54 Lodamin 54 indibulin 54 anti atherogenic 54 lucinactant 54 Bosutinib 54 HDACi 54 targeted radiotherapeutic 54 Curaxin CBLC# 54 QVAR 54 Omalizumab 54 mitogen activated ERK kinase 54 IL# PE#QQR 54 talabostat 54 ATL# [002] 54 Camptothecin 54 anti angiogenic therapy 54 DiLA2 54 thymosin beta 4 54 Nanobodies 54 compound AEZS 54 polycythemia vera PV 54 Pim kinases 54 immunomodulatory agents 54 anti fibrotic 54 Zolinza 54 macrolide antibiotics 54 UsiRNAs 54 chemopreventive agent 54 investigational therapies 54 PSN# [002] 54 Radient Pharmaceutical current 54 NSCLC tumors 54 PDE# inhibitors 54 Cotara ® 54 Hepatocellular Carcinoma 54 IAP inhibitor 54 novel peptides 54 HDL Mimetic Peptide 54 antiresorptive 54 inhibits protein synthesis 54 kallikrein 54 TRV# [001] 54 Ozarelix 54 protein biochip 54 RNA antagonist 54 DermaVir 54 dAbs 54 GRNVAC1 54 azacytidine 54 murine monoclonal antibody 54 intravesical instillation 54 RNAi therapeutic targeting PCSK9 54 Therapeutic Vaccine 54 Anticalin ® 54 human microdosing 54 TAKSTA 54 alpha#beta# integrin 54 ZK EPO 54 molecular biomarkers 54 ZFP Therapeutic TM 54 Fibroblast 54 Bezielle 54 HSP# inhibitors 54 endothelin receptor 53 Exherin TM 53 Bleomycin 53 Amplimexon 53 pertuzumab 53 selective androgen receptor modulator 53 Monoclonal Antibody 53 neuro protective 53 RNAi therapeutic targeting 53 AKT inhibitor 53 Myocet 53 Personalized Immunotherapy 53 anticancer therapies 53 Cathepsin S 53 PathHunter 53 5 Fluorouracil 53 Novavax VLP vaccine 53 Myeloperoxidase 53 Beta catenin pathway 53 immune modulator 53 DNA intercalator 53 Estrogen Receptor 53 drug eluting stent DES 53 Therapeutic antibodies 53 OMNARIS HFA 53 immunotoxins 53 PKC# 53 MOVIPREP ® 53 benzimidazole 53 sipuleucel T 53 PDE4 inhibitor 53 Bioral ® 53 RAV# 53 Parathyroid Hormone 53 omega interferon 53 pharmacodynamic markers 53 Silodosin 53 Aflibercept 53 ELISA kit 53 isoform selective 53 plasma kallikrein inhibitor 53 antiangiogenic therapy 53 OnDose 53 COX2 53 relapsed ALL 53 PROSTASCINT R 53 anti angiogenic drugs 53 hyaluronic acid dermal fillers 53 metastatic neuroendocrine tumors 53 Tß4 53 nonhuman primate model 53 cathepsin K 53 quinolone 53 vascular disrupting agents 53 Arcelis ™ 53 coronary stenting 53 Neoplasms 53 CCR9 53 torezolid phosphate 53 Phase IIb clinical trials 53 lenalidomide Revlimid 53 Antiangiogenic 53 uricase 53 Transfection Reagent 53 Panzem R 53 Cloretazine ® 53 anticancer agent 53 LT NS# 53 Cethrin R 53 ATG Fresenius S 53 Zybrestat 53 imatinib resistance 53 Vidaza azacitidine 53 Assay Kits 53 enzyme inhibitor 53 Alfacell proprietary ribonuclease 53 ghrelin antagonists 53 receptor blocker 53 Novosom 53 pan HDAC inhibitor 53 Cytolin R 53 protein kinase inhibitors 53 SYN# 53 pomalidomide 53 potently inhibit 53 Fibroblast Growth Factor Receptor 53 immunotherapy treatments 53 Guanilib 53 Biomerk Tumorgrafts 53 Maxy G# 53 Geron telomerase inhibitor 53 small molecule agonists 53 NK1 53 Ataluren 53 highly selective inhibitor 53 PET molecular imaging 53 anti amnesic 53 antiangiogenic agent 53 Elafin 53 neuroblastoma tumors 53 delipidation 53 tubulin polymerization 53 small molecule activator 53 5 HT4 receptor 53 SynCon TM DNA 53 JAK2 inhibitors 53 insulin sensitizing 53 glucokinase activator 53 CMV vaccine 53 ALN TTR 53 delta isoform 53 cleavable linker 53 TLR agonists 53 SGLT 53 Aliskiren 53 vitamin D analogs 53 Cloretazine 53 Initiate Clinical Trial 53 AMPAKINE 53 epothilone 53 transgenic mouse models 53 protein tyrosine phosphatase 1B 53 Theratope 53 Erbitux cetuximab 53 antiplatelet therapies 53 epothilones 53 Radezolid 53 telomerase therapeutic 53 Vidofludimus 53 verteporfin 53 mTOR mammalian target 53 Carfilzomib 53 small molecule tyrosine 53 IGF IR 53 Hedgehog Pathway Inhibitor 53 Initiates Clinical 53 gamma secretase inhibitors 53 Raptiva R 53 phosphatidylserine PS targeting 53 olaparib 53 tyrosine kinase inhibitor 53 HTS assay 53 Catena ® 53 CAMPATH 53 ALK inhibitor 53 ArQule Kinase Inhibitor Platform 53 BeneFIX 53 deCODE chemistry 53 SCIB1 53 DXL TM 53 erlotinib Tarceva 53 Cardiomyocytes 53 radiotracers 53 selective kinase inhibitor 53 vivo RNAi 53 cisplatin resistant 53 mTOR inhibitors 53 ONCONASE R 53 beta Estradiol 53 breast cancer metastasis 53 SMT C# 53 Elagolix 53 R#/MEM 52 Enbrel etanercept 52 ABLAVAR ® 52 Sildenafil Viagra 52 Annamycin 52 IAP inhibitors 52 GRNCM1 52 efaproxiral 52 abacavir Ziagen 52 Prolongs Survival 52 siRNA therapeutics 52 vivo preclinical 52 ImmuKnow R 52 busulfan 52 acetonide FA 52 BMS# 52 SERCA2a 52 antiviral compounds 52 allosteric modulation 52 angiogenesis inhibition 52 Intravenous Human 52 TOCOSOL Camptothecin 52 NEUGENE antisense 52 Romiplostim 52 Kinase Inhibitors 52 Tesmilifene 52 GPR# agonist 52 TLR antagonists 52 Vascugel 52 orally dosed 52 dotLab System 52 direct thrombin inhibitors 52 mecamylamine 52 Allogeneic 52 Th2 cytokines 52 Campath ® 52 Nektar PEGylation technology 52 multimodality imaging 52 antisense inhibitors 52 TLR9 agonists 52 VEGF receptor 52 amikacin 52 photodynamic 52 PI3K/Akt pathway inhibitor 52 inhibitor rofecoxib 52 Armed Antibodies 52 gastrin 52 Tyrosine Kinase Inhibitor 52 trodusquemine 52 Omacetaxine 52 Tumour Vascular Disrupting Agent 52 heterologous 52 Protexia ® 52 Luteinizing Hormone Releasing Hormone 52 ART# 52 Monoclonal antibody 52 antisense compounds 52 Interferon alfa 52 Reverse Cholesterol Transport 52 Virulizin R 52 investigational humanized monoclonal antibody 52 VivaGel ™ 52 oral prodrug 52 anticancer compound 52 p# antigen 52 huC# DM4 52 inhaled AAT 52 cidofovir 52 Abbokinase 52 histone deacetylase HDAC inhibitor 52 histone deacetylase inhibitors 52 Hodgkin lymphoma HL 52 anti CD3 antibody 52 DsiRNA 52 Civacir 52 Anti Tumor 52 CellPort Technologies 52 OXi# 52 Virulizin ® 52 EpiCeram 52 anti secretory 52 chemotherapeutic treatments 52 Pathway Inhibitor 52 PSMA antibody 52 Hsp# Inhibitor 52 Cytochrome P# 52 Fleximer 52 INT# [002] 52 viral kinetics 52 Aganocide ® 52 Iressa gefitinib 52 Kahalalide F 52 cardiac contractility 52 Systemic Delivery 52 molecularly targeted therapies 52 Corgentin 52 siRNA therapeutic 52 parthenolide 52 Epothilones 52 BiovaxID TM 52 punctal plug delivery 52 Pimavanserin 52 JAK inhibitor 52 TNF alpha inhibitor 52 Kamada AAT 52 Xencor XmAb 52 eTag assays 52 immunostimulant 52 antimetastatic 52 Cyclosert TM 52 Molecular imaging 52 GDIR 52 NOD SCID mice 52 pharmacokinetic interactions 52 miRview meso 52 teriflunomide 52 Modrenal R 52 HER2 antibody 52 COPREXA ™ 52 antibody MT# 52 Metabolic Disease 52 nanomedicines 52 enzyme inhibitors 52 BLP# Liposome Vaccine 52 Valortim TM 52 PROLARIS 52 pegfilgrastim 52 MenACWY 52 IFS 2C 52 MAb 52 Nilotinib 52 KL4 surfactant 52 CCR2 52 SuperAntibody 52 Micromet BiTE 52 CCR1 52 MyVax R 52 peptidic 52 MYOBLOC 52 Visonac TM 52 Proxinium TM 52 xCELLigence 52 bendamustine HCl 52 telomerase inhibitor 52 irreversible inhibitor 52 Vidaza R 52 Protease Inhibitors 52 immunostimulatory 52 EGIR 52 oral JAK1 52 aurora kinase 52 PARP inhibition 52 Tyrima 52 Chemokine 52 sorafenib Nexavar 52 siRNAs targeting 52 Cloretazine R 52 therapeutic regimens 52 ProMune 52 AQ4N 52 Sym# 52 stem cell mobilizer 52 Adult Stem Cell Therapy 52 AAV vectors 52 Drug Formulation 52 INTEGRILIN 52 pharmacodynamic properties 52 gastro intestinal inflammation 52 cetuximab Erbitux 52 PDE4 inhibitors 51 Novel Oral 51 osteopontin OPN 51 MOG #-# 51 HuCAL 51 Eraxis 51 Somatuline 51 Inhaled nitric oxide 51 peptide antigens 51 PLX cells 51 imatinib mesylate Gleevec 51 ALN PCS 51 menadione 51 Replacement Therapy 51 NAVISTAR R 51 ProSavin 51 glucagon receptor 51 Bendavia 51 Triolex 51 rifalazil 51 TTR gene 51 androgen receptor AR 51 modulator SERM 51 Cand5 51 Cancer Vaccines 51 druggable targets 51 PI3 kinase inhibitors 51 cyclin dependent kinase inhibitor 51 haematologic malignancies 51 metabolite identification 51 Monoclonal 51 initiated Phase Ib 51 LHRH agonist 51 forodesine 51 recombinant adeno associated 51 Six3 51 radiolabeled monoclonal antibody 51 GAP #B# 51 Lucanix 51 IgM antibody 51 nanoparticle formulation 51 orthoPACE 51 Preclinical Study 51 novel histone deacetylase 51 Sipuleucel T 51 Protein Expression 51 drug eluting coronary stent 51 Posiphen TM 51 polyclonal antibody 51 Aplidin R 51 bispecific antibody 51 bioabsorbable polymer 51 Troxatyl 51 JAK3 51 Biological Therapy 51 tumor antigen 51 RenaZorb TM 51 PCK# 51 SNALP technology 51 BioSTAR R 51 Vivecon 51 humanized anti 51 Mutational 51 Cetrorelix 51 inhibit angiogenesis 51 Protelos 51 peroxisome proliferator activated 51 lipid nanoparticle 51 quadrivalent HPV vaccine 51 Valortim ® 51 Selective Electrochemical Tumor Ablation 51 Loramyc R 51 Mepact 51 PlGF 51 perifosine KRX 51 EZN 51 Potelligent Technology 51 CRD5 51 EnVivo 51 seliciclib CYC# 51 rEV# 51 sd rxRNA 51 subunit vaccines 51 fosbretabulin 51 REMINYL ® 51 pharmacological chaperone 51 Mimetics 51 granisetron 51 hybridoma 51 immunomodulatory effects 51 Onco TCS 51 Zarnestra 51 RNAi Therapeutic 51 LEUKINE 51 Vitro Activity 51 TYZEKA 51 mTOR inhibitor 51 lentiviral 51 Denufosol 51 tkRNAi 51 NanoEmulsion 51 PPARγ 51 Virtual Histology 51 anti restenotic 51 Immunomodulatory 51 small molecule PEGylation 51 ibudilast 51 JVRS 51 CYT# potent vascular disrupting 51 compound CTCE 51 antisense oligonucleotide 51 CXCR4 receptor 51 Treanda bendamustine 51 TLK# 51 Bellicum Pharmaceuticals Inc. 51 IFN alpha 51 B Raf 51 OncoGel 51 antitumor responses 51 estrogen receptor beta 51 InNexus Biotechnology 51 therapeutically relevant 51 Medarex UltiMAb R 51 Photodynamic therapy PDT 51 S#P# 51 intranasal formulation 51 oral ghrelin agonist 51 JAK2 inhibitor 51 REG1 51 selective HDAC inhibitors 51 selective androgen receptor modulators 51 myeloproliferative disorders 51 trastuzumab Herceptin ® 51 Etravirine 51 mitochondrial enzyme 51 Aurora Kinase 51 Hydroxyurea 51 telomerase activators 51 KRN# 51 retroviral vectors 51 atacicept 51 Tyrosine Kinase Inhibitors 51 immune modulation 51 rxRNA ™ compounds 51 PRTX 51 Novel Therapeutic 51 VAPRISOL 51 alefacept 51 topical NSAID 51 demethylating agents 51 TLR antagonist 51 adenosine A2A 51 inhibit KSP 51 maturation inhibitor 51 Phase 1b clinical trials 51 multi kinase inhibitor 51 anti proliferative 51 Bryostatin 51 CRLX# 51 gamma secretase inhibitor 51 NS5A 51 ZEVALIN ® 51 CyPath ® 51 cytotoxic compounds 51 novel therapeutic antibodies 51 Ophena 51 XTEN 51 Alkaline Phosphatase 51 Neuroprotection 51 Wnt signaling pathway 50 cynomolgus monkeys 50 CCR5 antagonist 50 IFN α 50 chimeric antibody 50 nasally delivered 50 RezularTM 50 otelixizumab 50 Actemra tocilizumab 50 tiapamil 50 antimetabolite 50 subcutaneous immunoglobulin 50 MyVax ® 50 soluble receptor 50 DUROS 50 stratifying patients 50 pDNA vaccine 50 Tesetaxel 50 RNAi compounds 50 Multiferon R 50 OvaRex MAb 50 radiolabeling 50 lipid nanoparticles 50 novel prodrug 50 LEP ETU 50 isotype 50 #F FDG PET 50 ELACYT 50 phosphate S1P 50 Fc receptor 50 NSAID induced 50 Locked Nucleic Acid 50 streptococcal vaccine 50 topically administered 50 PI3K inhibitors 50 Somatuline ® 50 Nitrolingual 50 xCELLigence System 50 TACI Ig 50 RNase L 50 vivo electroporation 50 Novasome R 50 Vegenics 50 Isolagen Process 50 Chemoprevention 50 ARX# [001] 50 Anticancer Drug 50 Pharmacodynamic 50 non nucleoside HCV 50 MEK inhibitor RDEA# 50 prostatic tissue 50 Hypoxia Inducible Factor 50 selective antagonist 50 5 HT2C receptor 50 BioNumerik 50 coagulation cascade 50 metastatic colorectal 50 P#Y# [001] 50 Varespladib 50 Removab 50 compound perifosine 50 MORAb 50 rALLy clinical trial 50 candidate deforolimus 50 TREDAPTIVE 50 mGluR4 50 Hormone Refractory Prostate Cancer 50 antithrombotics 50 malignant ascites 50 eniluracil 50 pulsed electromagnetic field 50 SPRIX ® 50 protein CETP 50 QUADRAMET R 50 nucleoside analog 50 neuroprotectant 50 Ventavis ® 50 Telbivudine 50 PTP 1B 50 Huntexil 50 ATL# [001] 50 Demonstrates Efficacy 50 Stakeholder Opinions 50 Davanat 50 Etubics 50 PI3K/mTOR 50 immunoregulatory 50 ChronVac C R 50 Tezampanel 50 Immunosuppression 50 EGFR inhibition 50 buccal delivery